US 10022382
RNA polymerase I inhibitors and uses thereof
granted A61KA61K31/551A61P
Quick answer
US patent 10022382 (RNA polymerase I inhibitors and uses thereof) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
- Grant date
- Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/551, A61P, A61P25/00